| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | FIRST DATA CORP CL A | 1,581,821 | 20,816,000 | 25.87% | ||
| 2 | CAESARS ACQUISITION CO CL A | 1,665,032 | 20,679,000 | 25.70% | ||
| 3 | NOVOCURE LTD | 1,815,479 | 15,504,000 | 19.27% | ||
| 4 | CAESARS ENTMT CORP | 1,665,032 | 12,404,000 | 15.41% | ||
| 5 | TRANSENTERIX INC | 3,032,625 | 5,125,000 | 6.37% | ||
| 6 | Fidus Investment Corp | 260,105 | 4,096,000 | 5.09% | ||
| 7 | ALPHATEC HOLDINGS INC | 107,352 | 1,009,000 | 1.25% | ||
| 8 | QUINSTREET INC COM USD0.001 | 270,114 | 815,000 | 1.01% | ||
| 9 | ERICKSON INC | 36,735 | 24,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021723, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
